Poland· PL-100258787
Icandra
A metformin und vildagliptin product containing vildagliptinum + metformini hydrochloridum, registered in Poland by Novartis Europharm Limited. The same ATC class is registered in 11 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Metformin und vildagliptin is registered in 11 of 19 countries.
Countries holding a registration under ATC A10BD08 (metformin und vildagliptin), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Metformin und vildagliptin · ATC A10BD08
11 / 19 countries
- Belgiumprice
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Italyprice
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
The record
At a glance
URPL (Poland)- Active substance
- Vildagliptinum + Metformini hydrochloridum
- Manufacturer
- Novartis Europharm Limited
- Country
- Poland (PL)
- ATC code
- A10BD08
- ATC class
- Metformin und Vildagliptin
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 6
- gtin05909990910960
- gtin05909990910977
- gtin05909990910984
- gtin05909990910991
- gtin05909990911004
- gtin05909990911028
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
3 interactions on record for metformin und vildagliptin.
Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Metformin und vildagliptin · interactions on record
3 records
3 more interactions with mechanism and management, from a commercially licensed source.
Sign in to checkSame medicine, other countries
Metformin und vildagliptin in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaALIKVAL DUOEgis Pharmaceuticals PLC, Budapešť
- SpainDALTEX 50 MG/1000 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGMedochemie Limited
- United KingdomEucreas 50mg/1000mg tabletsCST Pharma Ltd
- ItalyEUCREASNOVARTIS EUROPHARM LTD
- SwitzerlandGalvumet
- SwedenEucreas 50 mg/1000 mg Filmdragerad tablettNovartis Europharm Limited
- FinlandEucreasParanova Oy
- NetherlandsEucreas 50 mg/1000 mg, filmomhulde tabletNovartis Europharm Limited
Authorised across Europe · EMA
The same active substance is authorised in 28 EEA countries. Names it is sold under:
- Austria · Melkart Duo, Sykurzuki
- Belgium · Vildagliptine/Metformine Krka
- Bulgaria · Melkart Duo, Vilspox
- Cyprus · Daltex, Radicut
- Czechia · Alikval Duo, Anvildis Duo
- Germany · Vildagliptin Metformin Zentiva, Vildagliptin/Metformin Heumann
- Denmark · Daltex, Diptivil Duo
- Estonia · Daltex, Vildagliptin/Metformin Hydrochloride Elvim
- Spain · Daltex, Ipinzan
- Finland · Vildagliptin/Metformin Krka, Vildagliptin/Metformin Ratiopharm
- France · Vildagliptine/Metformine Arrow, Vildagliptine/Metformine Biogaran
- United Kingdom (Northern Ireland) · Vildagliptin/Metformin Amarox, Vildagliptin/Metformin Hydrochloride Accord-Uk
- Greece · Dalmevin Plus, Euvilme
- Croatia · Daltex, Vilbaco Stada
- Hungary · Agartha Duo, Alikval Duo
- Iceland · Eucreas, Icandra
- Italy · Sykurzuki, Vildagliptin E Metformina Aurobindo
- Liechtenstein · Eucreas, Icandra
- Lithuania · Vildagliptin/Metformin Hydrochloride Elvim, Vimetso
- Latvia · Daltex, Vildagliptin/Metformin Hydrochloride Elvim
- Malta · Alikval Duo, Daltex
- Netherlands · Vilanovmet, Vildagliptine/Metformine Hcl Amarox
- Norway · Eucreas, Icandra
- Portugal · Daltex, Metformina + Vildagliptina
- Romania · Agartha Duo, Daltex
- Sweden · Vilbaco, Vildagliptin/Metformin Krka
- Slovenia · Daltex, Vimetso
- Slovakia · Anvildis Duo, Daltex
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e94a62eb-6b11-462a-96b2-fd7d9b5267e5 GET /v1/drugs/e94a62eb-6b11-462a-96b2-fd7d9b5267e5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "50 mg + 850 mg",
"packaging": "05909990910960 ¦ Rp ¦ EU/1/08/484/001 ¦ 70311\n10 tabl.\n05909990910977 ¦ Rp ¦ EU/1/08/484/002 ¦ 70312\n30 tabl.\n05909990910984 ¦ Rp ¦ EU/1/08/484/003 ¦ 70314\n60 tabl.\n05909990910991 ¦ Rp ¦ EU/1/04/484/004 ¦ 70315\n120 tabl.\n05909990911004 ¦ Rp ¦ EU/1/04/484/005 ¦ 70316\n180 tabl.\n05909990911028 ¦ Rp ¦ EU/1/08/484/006 ¦ 70317\n360 tabl.\nRp ¦ EU/1/08/484/019 ¦ 119844\n10 tabl.\nRp ¦ EU/1/08/484/020 ¦ 119845\n30 tabl.\nRp ¦ EU/1/08/484/021 ¦ 119846\n60 tabl.\nRp ¦ EU/1/08/484/022 ¦ 119847\n120 tabl.\nRp ¦ EU/1/08/484/031 ¦ 119848\n120 tabl. (2 x 60)\nRp ¦ EU/1/08/484/032 ¦ 119849\n180 tabl. (3 x 60)\nRp ¦ EU/1/08/484/023 ¦ 119850\n180 tabl.\nRp ¦ EU/1/08/484/033 ¦ 119851\n360 tabl. (6 x 60)\nRp ¦ EU/1/08/484/024 ¦ 119852\n360 tabl.\nRp ¦ EU/1/08/484/040 ¦ 148893\n120 tabl.\nRp ¦ EU/1/08/484/037 ¦ 148894\n10 tabl.\nRp ¦ EU/1/08/484/014 ¦ 148895\n18 tabl. (3x60) tabletek (opakowanie\nRp ¦ EU/1/08/484/041 ¦ 148896\n180 tabl.\nRp ¦ EU/1/08/484/015 ¦ 148897\n360 tabl. (6x60) tabletek (opakowanie zbiorcze)\nRp ¦ EU/1/08/484/039 ¦ 148898\n60 tabl.\nRp ¦ EU/1/08/484/043 ¦ 148899\n120 tabl. (2x60) tabletek (opakowanie zbiorcze)\nRp ¦ EU/1/08/484/013 ¦ 148900\n120 tabl. (2x60) tabletek (opakowanie\nRp ¦ EU/1/08/484/038 ¦ 148901\n30 tabl.\nRp ¦ EU/1/08/484/042 ¦ 148902\n360 tabl.\nRp ¦ EU/1/08/484/044 ¦ 148903\n180 tabl. (3x60) tabletek (opakowanie zbiorcze)\nRp ¦ EU/1/08/484/045 ¦ 148904\n360 tabl. (6x60) tabletek (opakowanie zbiorcze)",
"substance": "Vildagliptinum 50 mg + Metformini hydrochloridum 850 mg",
"common_name": "Vildagliptinum + Metformini hydrochloridum",
"pl_product_id": "100258787",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about metformin und vildagliptin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.